Bronchial resection margin length and clinical outcome in non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 5, 2011, Pages 1151-1156

  Tomaszek, Sandra C ^a   Kim, YeonSoo ^a,b   Cassivi, Stephen D ^a   Jensen, Matthew R ^a   Shen, Keh Hsien R ^a   Nichols, Francis C ^a   Deschamps, Claude ^a   Wigle, Dennis A ^a  

^a MAYO CLINIC   (United States)

^b Inje University College of Medicine   (South Korea)

Author keywords

Bronchus; Lung cancer; Outcome; Surgical margin; Surgical treatment

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AGED; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PNEUMONECTOMY; PROGNOSIS; TREATMENT OUTCOME;

EID: 80054008617     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.02.042     Document Type: Article

References (24)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., Tsuboi M., Vallières E., Goldstraw P. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602. International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions.
3. Cerfolio R.J., Bryant A.S. Survival of patients with true pathologic stage I non-small cell lung cancer. Ann Thorac Surg 2009, 88:917-922.
4. Kelsey C.R., Marks L.B., Hollis D., Hubbs J.L., Ready N.E., D'Amico T.A., Boyd J.A. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer 2009, 115:5218-5227.
5. Lardinois D., Suter H., Hakki H., Rousson V., Betticher D., Ris H.B. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 2005, 80:268-274.
6. Goodgame B., Viswanathan A., Zoole J., Gao F., Miller C.R., Subramanian J., Meyers B.F., Patterson A.G., Govindan R. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients. J Thorac Oncol 2009, 4:1370-1374.
7. Collaud S., Bongiovanni M., Pache J.C., Fioretta G., Robert J.H. Survival according to the site of bronchial microscopic residual disease after lung resection for non-small cell lung cancer. J Thorac Cardiovasc Surg 2009, 137:622-626.
8. Ghiribelli C., Voltolini L., Paladini P., Luzzi L., Di Bisceglie M., Gotti G. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump. Eur J Cardiothorac Surg 1999, 16:555-559.
9. Hofmann H.S., Taege C., Lautenschläger C., Neef H., Silber R.E. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. Eur J Cardiothorac Surg 2002, 21:606-610.
10. Riquet M., Achour K., Foucault C., Le Pimpec Barthes F., Dujon A., Cazes A. Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis. Ann Thorac Surg 2010, 89:870-875.
11. Kara M., Sak S.D., Orhan D., Yavuzer S. Changing patterns of lung cancer; (3/4in.) 1.9cm; still a safe length for bronchial resection margin?. Lung Cancer 2000, 30:161-168.
12. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., Postmus P.E., Rusch V., Sobin L. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:706-714. International Association for the Study of Lung Cancer International Staging Committee, Participating Institutions.
13. Sienel W., Stremmel C., Kirschbaum A., Hinterberger L., Stoelben E., Hasse J., Passlick B. Frequency of local recurrence following segmentectomy of stage IA non-small cell cancer is influenced by segment localization and width of resection margins-implications for patient selection for segmentectomy. Eur J Cardiothorac Surg 2007, 31:522-527.
14. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622.
15. Sawabata N., Ohta M., Matsumura A., Nakagawa K., Hirano H., Maeda H., Matsuda H. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg 2004, 77:415-420. Thoracic Surgery Study Group of Osaka University.
16. Borczuk A.C., Toonkel R.L., Powell C.A. Genomics of lung cancer. Proc Am Thorac Soc 2009, 6:152-158.
17. Guo M., House M.G., Hooker C., Han Y., Heath E., Gabrielson E., Yang S.C., Baylin S.B., Herman J.G., Brock M.V. Promoter hypermethylation of resected bronchial margins: a field defect of changes?. Clin Cancer Res 2004, 10:5131-5136.
18. Griess D.F., McDonald J.R., Clagett O.T. The proximal extension of carcinoma of the lung in the bronchial wall. J Thorac Surg 1945, 14:362-368.
19. Cotton R.E. The bronchial spread of lung cancer. Br J Dis Chest 1959, 53:142-150.
20. Takeda S., Maeda H., Koma M., Matsubara Y., Sawabata N., Inoue M., Tokunaga T., Ohta M. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience. Eur J Cardiothorac Surg 2006, 29:276-280.
21. Sladden M.J., Balch C., Barzilai D.A., Berg D., Freiman A., Handiside T., Hollis S., Lens M.B., Thompson J.F. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009, (4). CD004835.
22. Lens M.B., Dawes M., Goodacre T., Bishop J.A. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002, 137:1101-1105.
23. Moore H.G., Riedel E., Minsky B.D., Saltz L., Paty P., Wong D., Cohen A.M., Guillem J.G. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003, 10:80-85.
24. Widhe B., Bauer H.C. Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: a population-based Scandinavian Sarcoma Group study of 106 patients. J Thorac Cardiovasc Surg 2009, 137:610-614. Scandinavian Sarcoma Group.